C4A.62
Merkel cell carcinoma of left upper limb, including shoulder
Clinical Classification Guidelines
Medical Intelligence & Overview
Merkel cell carcinoma (MCC) is a rare but aggressive form of skin cancer that primarily appears on sun-exposed areas of the skin. When it occurs on the left upper limb, including the shoulder, it often presents as a fast-growing, painless skin nodule. Early diagnosis and treatment are essential for better outcomes. MCC mainly affects older adults and those with weakened immune systems. It is characterized by rapid growth and a high tendency to spread to lymph nodes and other parts of the body.
Causes & Symptoms
Clinical Causes: Prolonged exposure to ultraviolet (UV) radiation from the sun or tanning beds Weakened immune system, including conditions like HIV/AIDS or immunosuppressive treatments Older age, as MCC is more common in individuals over 50 History of excessive skin damage or previous skin cancers Possible genetic factors that may increase susceptibility
Key Symptoms: Fast-growing, firm, painless skin nodule or lump Color that can vary, including flesh-colored, blue, red, or purple Surface may be shiny or appear ulcerated Localized swelling or tenderness in some cases Rarely, ulceration or bleeding from the lesion
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a physical examination of the lesion, followed by a skin biopsy to confirm the presence of Merkel cell carcinoma cells. Additional tests, such as imaging studies (CT, MRI, PET scans), may be performed to determine whether the cancer has spread. Sentinel lymph node biopsy can assess lymphatic involvement and help stage the disease. Proper diagnosis is critical for planning appropriate treatment strategies.
Treatment Protocols: Treatment options generally include surgical removal of the tumor with clear margins, often combined with sentinel lymph node biopsy or dissection to evaluate lymphatic spread. Adjuvant radiation therapy may be recommended to reduce the risk of local recurrence. In some cases, immunotherapy drugs like immune checkpoint inhibitors are used to treat advanced or metastatic MCC. Close follow-up is essential to monitor for recurrence or spread. Because MCC is aggressive, early intervention enhances the likelihood of successful management.
Clinical Advice & FAQs
Billing Guidance
Is C4A.62 a billable ICD-10 code?
Yes, C4A.62 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C4A.62?
Clinical documentation must specify the nature of Merkel cell carcinoma of left upper limb, including shoulder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference